Non‐Cancer Causes of Death in Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Real‐World Analysis
The Prostate · 2026-07 · 86 (10) · 1170-1173
DOI: 10.1002/pros.70174 ↗Abstract
ABSTRACT Background As overall survival improves in metastatic hormone‐sensitive prostate cancer (mHSPC), non‐cancer causes of death are increasingly relevant. Methods We conducted a real‐world multicenter study of patients diagnosed with mHSPC treated with ADT alone or in combination. Causes of death before progression to castration‐resistant prostate cancer (CRPC) were classified as cancer‐ or non‐cancer‐related. Deaths were classified as non‐cancer‐related if they occurred in the absence of cancer progression. Results Among 565 patients, 35 (6.2%) died from non‐cancer‐related causes without disease progression, mainly infections (34%) and cardiovascular events (20%). Conclusions Non‐cancer mortality represents a meaningful proportion of deaths in mHSPC, supporting systematic cardiovascular risk evaluation and infection‐prevention strategies.
EUVIMED